ClinicalTrials.Veeva

Menu

Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program (PETRUS)

G

Gustave Roussy

Status

Completed

Conditions

Metastatic Castration Resistant Prostate Cancer Patients

Treatments

Other: metastasis biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT01786031
2012-A00668-35

Details and patient eligibility

About

Toward personalised treatment in early metastatic prostate cancer based on the assessment of biomarkers in cancer tissue samples and circulating tumour cells.

Enrollment

55 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Prostate Cancer patients
  • Castration Resistant
  • Prostatic tissue available
  • Metastasis which may be biopsied

Exclusion Criteria:

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

55 participants in 1 patient group

experimental
Experimental group
Description:
metastasis biopsy
Treatment:
Other: metastasis biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems